A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Tirzepatide; Drug: Placebo Sponsor: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: China Health | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Research | Study